✦ LIBER ✦

Contribution of BCR–ABL-independent activation of ERK1/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells

✍ Scribed by Takeru Nambu; Norie Araki; Aiko Nakagawa; Akihiko Kuniyasu; Tatsuya Kawaguchi; Akinobu Hamada; Hideyuki Saito

Book ID: 108586546
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 502 KB
Volume: 101
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2009.01365.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transcriptional activation of Skp2 by BC

Transcriptional activation of Skp2 by BCR-ABL in K562 chronic myeloid leukemia cells

✍ Jing-Yi Chen; Ming-Chung Wang; Wen-Chun Hung 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 540 KB

Bcr-Abl-induced tyrosine phosphorylation

Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells

✍ Jing-Yi Chen; Ming-Chung Wang; Wen-Chun Hung 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

## Abstract Our previous study demonstrates that Bcr‐Abl fusion oncogene frequently found in chronic myeloid leukemia (CML) cells can up‐regulate Skp2 expression via transcriptional activation. However, Bcr‐Abl also modulates Skp2 protein stability in these cells. Treatment of Bcr‐Abl kinase inhibi

JNK1/c-Jun and p38α MAPK/ATF-2 pathways

JNK1/c-Jun and p38α MAPK/ATF-2 pathways are responsible for upregulation of Fas/FasL in human chronic myeloid leukemia K562 cells upon exposure to Taiwan cobra phospholipase A2

✍ Ku-Chung Chen; Yi-Ling Chiou; Long-Sen Chang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB

## Abstract Fas and FasL expression upregulation was found in human leukemia K562 cells upon exposure to __Naja naja atra__ phospholipase A~2~ (PLA~2~). PLA~2~ treatment induced an increase in intracellular Ca^2+^ ([Ca^2+^]i) and ROS generation levels, leading to activation of p38 MAPK and JNK. Sup